January 14, 2015

Investor Information

MangoGen Pharma is a biotech company with a mission to develop novel approaches to deliver specific genes to promote and accelerate wound healing. 

The MangoGen team is dedicated to developing and producing a novel gene-delivering stent, gene-delivering film-dressings and gene-delivering sutures.

If you are interested in investment opportunities, please contact:

Paul Plested, CEO

+1 514-800-6872


For recent news about MangoGen go to: